Although the deleterious effects of exposure to ionizing radiation were first recognized and described over fifty years ago, the adequate treatment of these effects still remains a therapeutic challenge. At the present time, when increasing numbers of our population are being exposed to radiation because of the great increa3e in availability and use of radioactive isotopes and because of the potential exposure of much greater numbers of people to radiation following a~possible atomic bomb burst or from disseminated radioactivity, the need for development of adequate therapy is becoming an increasingly pressing medical problem.
In a consideration of possible approaches to therapy, one must dis-, tinguish between radiation fronl sources external to the body and radiation which results from radioactive materials which by some means or other have gained access into the body. Internally deposited radiation emitters can be particularly insidious since so many of them become fixed in the skeleton and are eliminated at very slow rates. v1hile it is possible to remove external sources of damaging radiation once the hazard is recognized, the internal radiatiorl emitters often are not readily displaced and the body remains exposed to prolonged continued radiation. vfuere long-lived elements, such as plutonium with a biological half-life of the order of 100 years l or radium with one of 45 years,2 are involved, the body can be subject to continuous radiation for UGRL-1351
injury. The effects of this type of chronic exposure to radiation are well documented in the case reports on radiwu poisoning in workers in the lununous dial
industry.] The damage is manifest in various forms, i.e., severe anenna, osteitis, and osteogenic sarcoma.
In the past, therapy to check injury from internal radiation emitters had been directed to attempts to ha3ten the elimination of the noxious agent.
These have included such methods as low calcium diets, parathormone, viosterol, '4,5 6 armnonium chloride, calcium gluconate, and 10vi phosphorus diets. Of these the decalcifying type of treatment was reported to have some measure of effectiveness. The results of the other types of therapy were equivocal.
The most successful approach was reported in the work of Schubert.?
Using zirconium citrate complex, administered 3 hours after the injection of radioyttrium and plutonium into rats, he was able to increase the urinary excretion of the injected radio elements many times over that of the excretion in the untreated rats, in some instance up by a factor of 50 for the first day of excretion. However, when used at later time periods, i.e., in a dog at 150 days, the increase in urinary excretion was only a factor of 2 to 3 over the control per>iod. The fecal excretion of the radio elements was not influenced by the treatment.
The present study reports a different approach for accelerating the excretion of radioelements, namely the use of chelating agents. Many of the rare earth and actinide series of elements form water-soluble chelates with various organic compounds. This consideration suggested the possibility that this property of chelating agents might be used "in vivo" to mobilize radioelements fixed within the body. Of the many compounds considered, ethylenediamine tetracetic acid (ED'fA) was chosen for this study. small doses, i.e., approximately 200 milligrams per kilo of body weight in rats. However, when administered combined with an equivalent weight of calcium ion, this negative calcium balance is prevented and the compound is rendered relatively non-toxic. Under these conditions the EDTA will still chelate a large number of metals, namely the metals which displace the caJ,bium from combination with the EDTA because they form more stable chelates. Fortunately, plutonium and many of the elements formed in fission' fall in 'this category.
Experimental
In the experiments to be~escribed, the following elements were used, namely (a) yttrium 9l , because it is a'relatively abundant fission product;
(b) cerium l44 , because it is one of'the~anthanide rare earths, and (c) plutonium 239 •.
.~..
All three of these elements are potentially serious health hazards in that they are bone seekers with long biological half-lives.
In all the experiments, female Curtis-Dunning rats weighing approximately 250 grams were employed. The yttrium experiment was performed using 5 groups of 3 rats each. ,~ach rat was injected intravenously with approximately 25~c of carrier-free y9l in 0.5 cc. of a solution of yttrium chloride in isotonic saline freshly adjusted to pH 6. rhe first group, A, was used as control and received no further treatment. The other groups each received calcium EDTA by different routes, intraperitoneally, intramuscularly, and by stomach tube under a time dosage schedule as indicated in Table 1 . The urine and feces were collected separately. The collection of 3 days excretion \vas lumped into groups except in the first 3 days, and the yttrium content assayed according to the method described by Scott et al. 9 The results were expressed on the basis ,of per cent of the originally administered dose per Table 2 . The feces and urine were collected separately daily. The excreta were assayed for plutonium ilnd cerium by methods previously used in this laboratory and described by Scott and co-workers. lO After 62 days the animals were sacrificed and tissues taken for assay. The results of the tissue assayvdll be presented in a future publication. The effect of the treatment on fecal excretion was much more difficult to determine because of the wide day-to-day variation. However, it appears that there was some small effect when the chelating agent was administered in the 20 through 23 day time period.
Plutonium: The results for plutonium are presented in Figures 3 and 40 The administration of the calcium EDTA at the time periods of 1 day and 13 through 18 days resulted in enhanced urinary excretion of the injected radioelement to levels which were approximately 10 times greater than that of the control animals.
The The marked enhancement of urinary excretion of the injected plutonium and radioyttrium which followed the administration of calcium EDTA and Fe-3 to rats strongly indicates that these agents are worthy of further investigation as a possible means of mobilizing internally deposited tadioelements.
It is apparent from a consideration of the above data that for effective therapy involving long-lived elements, prolonged continued treatment will be necessary even when as profound an alteration as a tenfold increase in the UCRL-135l excretion rate is effected. In the rat, at the time when plutonium is well-fixed in the body, the urinary-fecal ratio is approximately 1 to 10. Hence a tenfold increase in urinary excretion will not effect the overall excretion of the radioelement very markedly. In the human being the situation is more favorable. The urinary-fecal ratio when the plutonium is well-fixed in the body is approximately 1 . one to one and here a tenfold increas~in urinary excretion will result in an approximately tenfold increase in the total excretion of the plutonium. With an increase in the excretion rate of a factor of 10 the turn-over time in the body would be decreased. to 1/10 of that in untreated individuals, assuming that the treatment continues effective througho~t the entire therapy period. As was indicated above, 'with elements having very lon'g'turn-over times the treatment may have to be extended for a period of months or even years. In this 'connection it is of interest ·that repea,ted day-to..,d;ay·administration of chelating agents in this experiment continued to bring forth high levels of urinary radioelement excr:-etion. It, still remains to be seen,-of course, whether this effect could be brought about in humans.; It is. a re~sonable assumption.that the mechanism of the mobilization , , of radioelements is t!1e .formation of,wat~r-soluble chelates in the body, similar to the formation of chelates ,of, metals in the test tube. It is significant that the postulatio.n from "in. vitI'O" data that ,plutonium and yttrium would dis-
Dlace the calcium from combination with the EDTA was verified Hin vivo fl • One
can predict th~t strontiliJ:Ilwould not be mobilized from th~body by this treatment because of the fact-that :calciUlIl; forms a'much stronger chelate with EDTA than does strontium. From sim:Llar cons1.deration, one would not expect radium to be removed from the bodywithEDTA. Cerium is evidently a border~line Gase in that the relative affinity of EDTA for this element is only slightly greater 
